CVS Health Corporation

Last updated September 27, 2026

Organization details

Legal name
CVS Health Corporation
Former names
CVS Caremark Corp CVS Corp Melville Corp
Ownership
Public
Status
Active
SIC code
5912 — Retail-Drug Stores and Proprietary Stores
Jurisdiction of incorporation
Delaware
Headquarters city
Woonsocket
Headquarters state / province
Rhode Island
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CVS
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000064803
EIN
05-0494040

Board of directors

Chief executives

J. David Joyner · President and CEO
Dates unknown
Karen S. Lynch · President and CEO
Dates unknown

Director election results

Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

14 of this board's directors also sit on 19 other boards.

Network of CVS Health Corporation's board connections Boston Scientific Corporation Boston Scientific Corp... Arrive AI Inc. Arrive AI Inc. Arvinas Inc. Arvinas Inc. Automatic Data Processing Inc. Automatic Data Process... Baxter International Inc. Baxter International I... Brookdale Senior Living Inc. Brookdale Senior Livin... Butterfly Network Inc. Butterfly Network Inc. Globus Medical Inc. Globus Medical Inc. HCA Healthcare Inc. HCA Healthcare Inc. Morgan Stanley Morgan Stanley Neurocrine Biosciences Inc. Neurocrine Biosciences... OneMain Holdings Inc. OneMain Holdings Inc. Pediatrix Medical Group Inc. Pediatrix Medical Grou... Synchrony Financial Synchrony Financial The Progressive Corporation The Progressive Corpor... Thermo Fisher Scientific Inc Thermo Fisher Scientif... Douglas H. Shulman Douglas H. Shulman Edward J. Ludwig Edward J. Ludwig Fernando Aguirre Fernando Aguirre Guy P. Sansone Guy P. Sansone John E. Gallina John E. Gallina Karen S. Lynch Karen S. Lynch Larry Robbins Larry Robbins Leslie Norwalk V Leslie Norwalk V Mary L. Schapiro Mary L. Schapiro Michael F. Mahoney Michael F. Mahoney CVS Health Corporation
Shared director Other board Same sector +3 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$323,709,755
8 sales by 2 insiders
Date Insider Transaction Shares Price Value
Jun 26, 2026 Clark James David Officer (SVP, Cont & Chief Acct Officer) Shares withheld for tax −454 $90.98 $41,305
May 31, 2026 Brian Newman Officer (EVP, Chief Financial Officer) Shares withheld for tax −2,478 $90.98 $225,448
May 31, 2026 Compton-Phillips Amy Officer (EVP, Chief Medical Officer) Shares withheld for tax −7,618 $90.98 $693,086
May 21, 2026 Fernando Aguirre Director Sold back to the company −1,563 $93.50 $146,141
May 21, 2026 Larry Robbins Director Open-market sale −370,462 $93.45 $34,619,674
May 20, 2026 Fernando Aguirre Director Sold back to the company −30,437 $93.78 $2,854,382
May 20, 2026 Larry Robbins Director Open-market sale −797,628 $93.48 $74,562,265
May 20, 2026 Larry Robbins Director Open-market sale −152,691 $94.81 $14,476,634
May 20, 2026 Larry Robbins Director Open-market sale −66,881 $95.67 $6,398,505
May 20, 2026 Larry Robbins Director Open-market sale −800 $96.28 $77,024
May 19, 2026 Larry Robbins Director Open-market sale −1,983,387 $94.45 $187,330,902
May 19, 2026 Larry Robbins Director Open-market sale −151 $95.18 $14,372
May 14, 2026 Fernando Aguirre Director Grant or award +1,563 $97.15 $151,845
May 14, 2026 Jeffrey R. Balser Director Grant or award +2,058 $97.15 $199,935
May 14, 2026 J. Scott Kirby Director Grant or award +1,447 $97.15 $140,576

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.